Literature DB >> 19218638

Concentration of matrix metalloproteinase-9 in serum of patients with chronic obstructive pulmonary disease and a degree of airway obstruction and disease progression.

B Brajer1, H Batura-Gabryel, A Nowicka, B Kuznar-Kaminska, A Szczepanik.   

Abstract

Chronic obstructive pulmonary disease (COPD) is chronic inflammation leading to irreversible airway obstruction. Previous studies showed increased metalloproteinases (MMP) level, especially MMP-9, as a sign of local inflammation. Up-to-date, only a few studies estimated the MMP-9 serum concentration in COPD with respect to correlation with systemic inflammation. The aim of the present study was to estimate the MMP-9 serum concentration in COPD and to evaluate the correlation between MMP-9 and a degree of airway obstruction in COPD. Twenty three COPD patients and 23 healthy controls were enrolled. In both groups spirometry was performed. MMP-9 concentration in sera taken from both groups was studied using ELISA. We found that COPD patients had increased serum MMP-9 concentration compared with the control group (P=0.0005). In the COPD group, the MMP-9 levels were negatively correlated with FEV1 (P=0.01) and FEV1/FVC (P=0.0002). In conclusion, the results suggest that MMP-9 plays an important role in systemic inflammation in COPD. Higher MMP-9 serum concentration is connected with higher airway obstruction and disease progression.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19218638

Source DB:  PubMed          Journal:  J Physiol Pharmacol        ISSN: 0867-5910            Impact factor:   3.011


  27 in total

Review 1.  Fibrotic response of tissue remodeling in COPD.

Authors:  Lina María Salazar; Ana Milena Herrera
Journal:  Lung       Date:  2011-02-02       Impact factor: 2.584

Review 2.  Biomarkers of progression of chronic obstructive pulmonary disease (COPD).

Authors:  Janet G Shaw; Annalicia Vaughan; Annette G Dent; Phoebe E O'Hare; Felicia Goh; Rayleen V Bowman; Kwun M Fong; Ian A Yang
Journal:  J Thorac Dis       Date:  2014-11       Impact factor: 2.895

3.  Matrix Metalloproteinase-9 (279R/Q) Polymorphism is Associated with Clinical Severity and Airflow Limitation in Tunisian Patients with Chronic Obstructive Pulmonary Disease.

Authors:  Sarra Bchir; Hela Ben Nasr; Imen Rekik Hakim; Amel Ben Anes; Saloua Yacoub; Abdelhamid Garrouch; Mohamed Benzarti; Brigitte Bauvois; Zouhair Tabka; Karim Chahed
Journal:  Mol Diagn Ther       Date:  2015-12       Impact factor: 4.074

4.  Correlation of circulating MMP-9 with white blood cell count in humans: effect of smoking.

Authors:  Soren Snitker; Keming Xie; Kathleen A Ryan; Daozhan Yu; Alan R Shuldiner; Braxton D Mitchell; Da-Wei Gong
Journal:  PLoS One       Date:  2013-06-25       Impact factor: 3.240

5.  Matrix metalloproteinase-9 predicts pulmonary status declines in α1-antitrypsin deficiency.

Authors:  Theodore A Omachi; Mark D Eisner; Alexis Rames; Lada Markovtsova; Paul D Blanc
Journal:  Respir Res       Date:  2011-03-23

6.  Role of aberrant metalloproteinase activity in the pro-inflammatory phenotype of bronchial epithelium in COPD.

Authors:  Irene H Heijink; Simone M Brandenburg; Jacobien A Noordhoek; Dirk-Jan Slebos; Dirkje S Postma; Antoon J van Oosterhout
Journal:  Respir Res       Date:  2011-08-23

7.  COPD association and repeatability of blood biomarkers in the ECLIPSE cohort.

Authors:  Jennifer A Dickens; Bruce E Miller; Lisa D Edwards; Edwin K Silverman; David A Lomas; Ruth Tal-Singer
Journal:  Respir Res       Date:  2011-11-04

8.  Therapy with plasma purified alpha1-antitrypsin (Prolastin®) induces time-dependent changes in plasma levels of MMP-9 and MPO.

Authors:  Janine Koepke; Marc Dresel; Severin Schmid; Timm Greulich; Björn Beutel; Bernd Schmeck; Claus Franz Vogelmeier; Sabina Janciauskiene; Andreas Rembert Koczulla
Journal:  PLoS One       Date:  2015-01-30       Impact factor: 3.240

9.  Matrix Metalloproteinase-9 Production following Cardiopulmonary Bypass Was Not Associated with Pulmonary Dysfunction after Cardiac Surgery.

Authors:  Tso-Chou Lin; Feng-Yen Lin; Yi-Wen Lin; Che-Hao Hsu; Go-Shine Huang; Zhi-Fu Wu; Yi-Ting Tsai; Chih-Yuan Lin; Chi-Yuan Li; Chien-Sung Tsai
Journal:  Mediators Inflamm       Date:  2015-07-27       Impact factor: 4.711

10.  ADAM17 mediates MMP9 expression in lung epithelial cells.

Authors:  Ya-qing Li; Jian-ping Yan; Wu-lin Xu; Hong Wang; Ying-jie Xia; Hui-jun Wang; Yue-yan Zhu; Xiao-jun Huang
Journal:  PLoS One       Date:  2013-01-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.